Lactic Acid Bacteria Improves Peyer’s Patch Cell-Mediated Immunoglobulin A and Tight-Junction Expression in a Destructed Gut Microbial Environment
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
To evaluate the effects of lactic acid bacteria (LAB) on Peyer’s patch cells, mice were treated with a high dose of kanamycin to disturb the gut microbial environment. The overarching goal was to explore the potential of LAB for use as a dietary probiotic that buffers the negative consequences of antibiotic treatment. In vitro, LAB stimulated the production of immunoglobulin A (IgA) from isolated Peyer’s patch cells. Inflammation-related genes (TNF-α, IL-1β, and IL-8) were up-regulated in Caco-2 cells stimulated with lipopolysaccharide (LPS), while tight-junction-related genes (ZO-1 and occludin) were down-regulated; the effects of LPS on inflammatory gene and tight-junction gene expression were reversed by treatment with LAB. Mice treated with a high dose of kanamycin showed increased serum IgE levels and decreases in serum IgA and fecal IgA levels; the number of Peyer’s patch cells decreased with kanamycin treatment. However, subsequent LAB treatment was effective in reducing the serum IgE level and recovering the serum IgA and fecal IgA levels, as well as the number of Peyer’s patch cells. In addition, ZO-1 and occludin mRNA levels were up-regulated in the ileum tissues of mice receiving LAB treatment. Lactic acid bacteria can enhance the intestinal immune system by improving the integrity of the intestinal barrier and increasing the production of IgA in Peyer’s patches. Lactic acid bacteria should be considered a potential probiotic candidate for improving intestinal immunity, particularly in mitigating the negative consequences of antibiotic use.
Abstract
To evaluate the effects of lactic acid bacteria (LAB) on Peyer’s patch cells, mice were treated with a high dose of kanamycin to disturb the gut microbial environment. The overarching goal was to explore the potential of LAB for use as a dietary probiotic that buffers the negative consequences of antibiotic treatment. In vitro, LAB stimulated the production of immunoglobulin A (IgA) from isolated Peyer’s patch cells. Inflammation-related genes (TNF-α, IL-1β, and IL-8) were up-regulated in Caco-2 cells stimulated with lipopolysaccharide (LPS), while tight-junction-related genes (ZO-1 and occludin) were down-regulated; the effects of LPS on inflammatory gene and tight-junction gene expression were reversed by treatment with LAB. Mice treated with a high dose of kanamycin showed increased serum IgE levels and decreases in serum IgA and fecal IgA levels; the number of Peyer’s patch cells decreased with kanamycin treatment. However, subsequent LAB treatment was effective in reducing the serum IgE level and recovering the serum IgA and fecal IgA levels, as well as the number of Peyer’s patch cells. In addition, ZO-1 and occludin mRNA levels were up-regulated in the ileum tissues of mice receiving LAB treatment. Lactic acid bacteria can enhance the intestinal immune system by improving the integrity of the intestinal barrier and increasing the production of IgA in Peyer’s patches. Lactic acid bacteria should be considered a potential probiotic candidate for improving intestinal immunity, particularly in mitigating the negative consequences of antibiotic use.
참고문헌 (56)
- Abbas AK, "Die and let live: eliminating dangerous lymphocytes", Cell, 84, pp.655~657 (1996)
- Al-Sadi RM, "IL-1b causes an increase in epithelial tight junction permeability", Intest. J. Immunol, 178, pp.4641~4649 (2007)
- Andre C, "Interference of oral immunization with the intestinal absorption of heterologous albumin", Eur. J. Immunol, 4, pp.701~704 (1974)
- Angrisano T, "LPS-induced IL-8 activation in human intestinal epithelial cells is accompanied by specific histone H3 acetylation and methylation changes", BMC Microbiol, 10, pp.172~180 (2010)
- Barbara G, "Mucosal barrier defects in irritable bowel syndrome: who left the door open", Am. J. Gastroenterol, 101, pp.1295~1298 (2006)
- Bazzoni G, "Endothelial cell-to-cell junctions:molecular organization and role in vascular homeostasis", Physiol. Rev, 84, pp.869~901 (2004)
- Boullier S, "Secretory IgA-mediated neutralization of Shigella flexneri prevents intestinal tissue destruction by down-regulating inflammatory circuits", J. Immunol, 183, pp.5879~5885 (2009)
- Bruewer M, "Inflammatory bowel disease and the apical junctional complex", Ann. NY Acad. Sci, 1072, pp.242~252 (2006)
- Cunningham-Rundles C, "Physiology of IgA and IgA deficiency", J. Clin. Immunol, 21, pp.303~309 (2001)
- Farquhar MG, "Junctional complexes in various epithelia", J. Cell Biol, 17, pp.375~412 (1963)
- Feldman GJ, "Occludin: structure, function and regulation", Adv. Drug Deliver. Rev, 57, pp.883~917 (2005)
- Fuller R, "Probiotics in man and animals", J. Appl. Bacteriol, 66, pp.365~378 (1989)
- Guttman JA, "Evidence that tight junctions are disrupted due to intimate bacterial contact and not inflammation during attaching and effacing pathogen infection in vivo", Infect. Immun, 74, pp.6075~6084 (2006)
- Hart A, "Review article: mechanisms of initiation and perpetuation of gut inflammation by stress", Aliment. Pharmacol. Ther, 16, pp.2017~2028 (2002)
- Hosono A, "Characterization of a watersoluble polysaccharide fraction with immunopotentiating activity from Bifidobacterium adolescentis M101-4", Biosci. Biotechnol. Biochem, 61, pp.312~316 (1997)
- Kraehenbuhl JP, "Epithelial M cells:differentiation and function", Annu. Rev. Cell Dev. Biol, 16, pp.301~332 (2000)
- Lim BO, "Effect of dietary pectin on the production of immunoglobulins and cytokines by mesenteric lymph node lymphocytes in mouse colitis induced with dextran sulfate sodium", Biosci. Biotechnol. Biochem, 67, pp.1706~1712 (2003)
- Liu Z, "Tight junctions, leaky intestines, and pediatric diseases", Acta Paediatr, 94, pp.386~393 (2005)
- Macpherson AJ, "A primitive T cellindependent mechanism of intestinal mucosal IgA responses to commensal bacteria", Science, 288, pp.2222~2226 (2000)
- Macpherson AJ, "IgA responses in the intestinal mucosa against pathogenic and non-pathogenic microorganisms", Microbes Infect, 3, pp.1021~1035 (2001)
- Maes M, "The cytokine hypothesis of depression:inflammation, oxidative & nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression", Neuroendocrinol. Lett, 29, pp.287~291 (2008)
- Maes M, "Normalization of leaky gut in chronic fatigue syndrome (CFS) is accompanied by a clinical improvement: effects of age, duration of illness and the translocation of LPS from gram-negative bacteria", Neuroendocrinol. Lett, 29, pp.902~910 (2008)
- Makino H, "Mother-to-infant transmission of intestinal bifidobacterial strains has an impact on the early development of vaginally delivered infant’s microbiota", PLoS One, 8, pp.e78331~ (2013)
- Manichanh C, "Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach", Gut, 55, pp.205~211 (2006)
- Matsumoto M, "Promotion of intestinal peristalsis by Bifidobacterium spp. capable of hydrolysing sennosides in mice", PLoS One, 7, pp.e31700~ (2012)
- McGhee JR, "The mucosal immune system:from fundamental concepts to vaccine development", Vaccine, 10, pp.75~88 (1992)
- McGuckin MA, "Intestinal barrier dysfunction in inflammatory bowel diseases", Inflamm. Bowel Dis, 15, pp.100~113 (2009)
- Mullin J, "Ageand diet-related increase in transepithelial colon permeability of Fischer 344 rats", Dig. Dis. Sci, 47, pp.2262~2270 (2002)
- Naomi O, "Antibiotic use during infancy promotes a shift in the Th1", Th2 balance toward Th2-dominant immunity in mice, 2001, pp.107, 153~159
- Oboki K, "Th17 and allergy", Allergol. Int, 57, pp.121~134 (2008)
- Orban JI, "Modification of the phosphoketolase assay for rapid identification of bifidobacteria", J. Microbiol. Methods, 40, pp.221~224 (2000)
- Oyama N, "Antibiotic use during infancy promotes a shift in the T(H)1", T(H)2 balance toward T(H)2-dominant immunity in mice, 2001, pp.107, 153~159
- Penders J, "The role of the intestinal microbiota in the development of atopic disorders", Allergy, 62, pp.1223~1236 (2007)
- Perdigon G, "Intestinal pathway of internalization of lactic acid bacteria and gut mucosal immunostimulation", Int. J. Immunopathol. Pharmacol, 13, pp.141~150 (2000)
- Perdigon G, "Study of the possible mechanisms involved in the mucosal immune system activation by lactic acid bacteria", J. Dairy Sci, 82, pp.1108~1114 (1999)
- Rey J, "Targeting of secretory IgA to Peyer’s patch dendritic and T cells after transport by intestinal M cells", J. Immunol, 172, pp.3026~3033 (2004)
- Rupnik M, "Clostridium difficile infection: new developments in epidemiology and pathogenesis", Nat. Rev. Microbiol, 7, pp.526~536 (2009)
- Sandek A, "The emerging role of the gut in chronic heart failure", Curr. Opin. Clin. Nutr. Metab. Care, 11, pp.632~639 (2008)
- Schiffrin EJ, "Immune modulation of blood leukocytes in humans by lactic acid bacteria: criteria for strain selection", Am. J. Clin. Nutr, 66, pp.515S~520S (1997)
- Sekirov I, "Gut microbiota in health and disease", Physiol. Rev, 90, pp.859~904 (2010)
- Silbart LK, "Reduction of intestinal carcinogen absorption by carcinogen-specific secretory immunity", Science, 243, pp.1462~1464 (1989)
- Hyun Joo Song, "Antibiotic-Associated Diarrhea: Candidate Organisms other than Clostridium Difficile", The Korean Journal of Internal Medicine, 23(1), pp.9~15 (2008), 대한내과학회
- Stokes CR, "Immune exclusion is a function of IgA", Nature, 255, pp.745~746 (1975)
- Sudo N, "An oral introduction of intestinal bacteria prevents the development of a long-term Th2-skewed immunological memory induced by neonatal antibiotic treatment in mice", Clin. Exp. Allergy, 32, pp.1112~1116 (2002)
- Nakagawa E, "Effects of orally ingested Bifidobacterium longum on the mucosal IgA response of mice to dietary antigens", Biosci. Biotechnol. Biochem, 62, pp.10~15 (1998)
- Thitaram SN, "Bifidobacteriumselective isolation and enumeration from chicken caeca by a modified oligosaccharide antibiotic-selective agar medium", Lett. Appl. Microbiol, 41, pp.355~360 (2005)
- Ubeda C, "Antibiotics, microbiota, and immune defense", Trends Immunol, 33, pp.459~466 (2012)
- Vaarala O, "The “perfect storm”for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity", Diabetes, 57, pp.2555~2562 (2008)
- Vanderploeg R, "Influences of intestinal bacteria in human inflammatory bowel disease", Infect. Dis. Clin. North Am, 24, pp.977~993 (2010)
- Van Itallie CM, "Claudins and epithelial paracellular transport", Annu. Rev. Physiol, 68, pp.403~429 (2006)
- Van Itallie CM, "Occludin confers adhesiveness when expressed in fibroblasts", J. Cell Sci, 110, pp.1113~1121 (1997)
- Wachtel M, "Down-regulation of occludin expression in astrocytes by tumour necrosis factor (TNF) is mediated via TNF type-1 receptor and nuclear factor-κB activation", J. Neurochem, 78, pp.155~162 (2001)
- Wilcox MH, "Gastrointestinal disorders and the critically ill. Clostridium difficile infection and pseudomembranous colitis", Best Pract. Res. Clin. Gastroenterol, 17, pp.475~493 (2003)
- Yamada K, "Effect of dietary fiber on the lipid metabolism and immune function of aged Sprague-Dawley rats", Biosci. Biotechnol. Biochem, 67, pp.429~433 (2003)
- Yan F, "Probiotics: progress toward novel therapies for intestinal diseases", Curr. Opin. Gastroenterol, 26, pp.95~101 (2010)
- Young VB, "Antibiotic-associated diarrhea accompanied by large-scale alterations in the composition of the fecal microbiota", J. Clin. Microbiol, 42, pp.1203~1206 (2004)